Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-ceIl line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets

Blood

Volumn 87, Issue 1, 1996, Pages 393-403

  Cesano, Alessandra ^b   Pierson, Giuliana ^b   Visonneau, Sophie ^b   Migliaccio, Anna Rita ^b   Santoli, Daniela ^a  

^a WISTAR INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

ANIMALS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; BONE TRANSPLANTATION; BURKITT LYMPHOMA; CHILD; CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; FETAL TISSUE TRANSPLANTATION; GAMMA RAYS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LEUKEMIA; LEUKEMIA, T-CELL, ACUTE; LYMPHOKINES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, SCID; NEOPLASM, RESIDUAL; NEOPLASMS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030031806     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.393.393     Document Type: Article

References (43)

1. Storb R: Marrow transplantation for the treatment of malignant diseases, in Morris PJ, Tilney NL (eds): Progress in Transplantation. New York, NY, Churchill Livingstone, 1984, p 46
2. Meagher RC, Lowder JN, Herzig RH: Aspects of bone marrow preparation for autologous and allogeneic transplantation in the treatment of hematologic malignancies, in Wiernick PH, Canellos GP, Kyle RA, Schiffer CA (eds): Neoplastic Diseases of the Blood (ed 2). New York, NY Churchill Livingstone, 1991, p 913
3. Sharkis SJ, Santos GW, Colvin MD: Elimination of acute myelogenous leukemia cells from bone marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood 55:521, 1980
4. Sieber F, Spivak JL, Sutcliffe AM: Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc Natl Acad Sci USA 81:7584, 1984
5. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
6. Gribben JG, Saporito L, Barber M, Blake KW, Edwards RM, Griffin JD, Freedman AS, Nadler LM: Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083, 1992
7. Vitetta ES, Thorpe PE, Uhr JW: Immunotoxins: Magic bullets or misguided missiles? Immunol Today 14:252, 1993
8. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May WS, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR: Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141, 1986
9. Gulati S, Acaba L, Yahalom J, Reich L, Motzer R, Crown J, Doherty M, Clarkson B, Berman E, Atzpodien J, Andreeff M, Gee T: Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone Marrow Transplant 10:129, 1992
10. Herrman RP, O'Reilly J, Meyer BF, Lazzaro G: Prompt haemopoietic reconstitution following hypertemia purged autologous marrow and peripheral stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 10:293, 1992
11. Singer CRJ, Linch DC, Bown SG, Huehns ER, Goldstone AH: Differential phthalocyanine photosensitization of acute myeloblastic leukemia progenitor cells. A potential purging technique for autologous bone marrow transplantation. Br J Haematol 68:417, 1988
12. Fabrega S, Laporte JP, Giarratana MC, Douay L, Fouillard L, Da WM, Perrot C, Barbu V, Gorin NC: Polymerase chain reaction: A method for monitoring tumor cell purge by long-term culture in BCR/ABL positive acute lymphoblastic leukemia. Bone Marrow Transplant 11:169, 1993
13. Chang J, Dexter TM: Long-term marrow cultures: In vitro purging of leukaemic cells Baillieres Clin Haematol 4:775, 1991
14. Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NK: Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9 and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 79:1094, 1992
15. Handin RI, Lux SE, Stossel TP: Autologous Marrow Transplantation in Blood: Principles and Practice of Hematology. Philadelphia, PA, Lippincott, 1995
16. O'Connor R, Cesano A, Lange B, Finan J, Nowell PC, Clark SC, Raimondi S, Rovera G, Santoli D: Growth factor requirements of childhood acute T-lymphoblastic leukemia: Correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood 77:153, 1991
17. Cesano A, Santoli D: Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity: Analysis and modulation of their lytic mechanisms. In Vitro Cell Dev Biol 28A:648, 1992
18. Cesano A, Visonneau S, Santoli D: Treatment of experimental glioblastoma with a human MHC non-restricted cytotoxic T-cell line. Cancer Res 55:96, 1995
19. Cesano A, Visonneau S, Clark SC, Santoli D: Cellular and molecular mechanisms of activation of MHC non-restricted cytotoxic cells by IL-12 J Immunol 151:2943, 1994
20. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santoli D: Homing and progression patterns of childhood acute lymphoblas-tic leukemia in severe combined immunodeficient mice. Blood 77:2463, 1991
21. Cesano A, Visonneau S, Cioé L, Clark SC, Santoli D: Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T-cell clone potentially useful in cancer therapy. Cancer Immunol Immunother 40:139, 1995
22. Cesano A, Visonneau S, Cioé L, Clark SC, Rovera G, Santoli D: Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer aproach. J Clin Invest 94:1076, 1994
23. Shih IM, Elder DE, Hsu MY, Herlyn M: Regulation of Mel-CAM/MUC18 expression on melanocytes at different stages of tumor progression by normal keratinocytes. Am J Pathol 145(4):837, 1994
24. Gilboa E, Eglitis MA, Kautoff PW, Anderson WF: Transfer and expression of cloned genes using retroviral vectors. Biotechniques 4:504, 1986
25. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M: Lipofectin: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413, 1987
26. - cord blood cells stimulated with stem cell factor and interleukin 3. Blood 84:3667, 1994
27. +++ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41, 1993
28. Fauser AA, Messner HA: Granuloerythropoietic colonies in human bone marrow. Blood 52:1243, 1978
29. Cesano A, Santoli D: Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α and interferon-γ in two human cytotoxic leukemic T cell lines. In Vitro Cell Dev Biol 28A:657, 1992
30. Feinberg A, Volgestain B: A technique for radiolabeling DNA restriction endonuclease fragments to high specificity activity Anal Biochem 137:266, 1984
31. Namikawa R, Veda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID mice. Blood 82:2526, 1993
32. Trinchieri G, Murphy M, Perassia B: Regulation of hematopoiesis by T lymphocytes and natural killer cells. Critical Rev Oncol Hematol 7:219, 1987
33. Degliantoni G, Perussia B, Mangoni L, Trinchieri G: Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med 161:1152, 1985
34. Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G: Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor: Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med 162:1512, 1985
35. Kashara T, Dieu JY, Dougherthy SF, Oppenheim JJ: Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor. J Immunol 131:2379, 1983
36. Pistoia V, Gio R, Nocera A, Leprine A, Perata A, Ferrarini M: Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units. Blood 65:464, 1985
37. Holmberg LA, Miller BA, Ault KA: The effect of natural killer cells on the development of syngeneic hematopoietic progenitors. J Immunol 133:2933, 1984
38. Nagler A, Greenberg PL, Lanier LL, Phillips JH: The effects of recombinant interleukin-2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors. J Exp Med 168:47, 1988
39. Vujanovic NL, Herberman RB, Hiserodt JC: Lymphokine-activated killer cells in rats: Analysis of tissue and strain distribution, ontogeny and target specificity. Cancer Res 48:878, 1988
40. Rayner AA, Grimm EA, Lotze MT, Chu EW, Rosenberg SA: Lymphokine activated killer (LAK) cells: Analysis of factors relevant to the immunotherapy of human cancer. Cancer 55:1327, 1985
41. Van den Brink MRM, Voogt PJ, Marijt WAF, Van Luxeinburg-Heys SAP, Van Rood JJ, Brand A: Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stern cell function in vitro. Blood 79:354, 1989
42. + lymphocytes. J Immunol 142:1774, 1989
43. Long GS, Hiserodt JC, Harnaha JB, Cramer DV: Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation. Transplantation 46:433, 1988